Clover Health Investments Financial Statements (CLOV)
|
|
|
|
Report date
|
|
|
31.12.2019 |
31.03.2021 |
28.02.2022 |
01.03.2023 |
14.03.2024 |
|
08.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
462.3 |
672.9 |
1 472 |
3 477 |
2 034 |
|
1 368 |
|
Operating Income, bln rub |
|
|
-183.2 |
-92.7 |
-637.0 |
-370.9 |
-208.5 |
|
-55.1 |
|
EBITDA, bln rub |
? |
|
-182.6 |
-78.7 |
-569.6 |
-337.0 |
-210.8 |
|
-53.6 |
|
Net profit, bln rub |
? |
|
-402.8 |
-148.7 |
-604.7 |
-305.4 |
-213.4 |
|
-3.49 |
|
|
OCF, bln rub |
? |
|
-159.9 |
-2.23 |
-282.3 |
-203.9 |
-115.9 |
|
207.2 |
|
CAPEX, bln rub |
? |
|
0.023 |
0.693 |
0.723 |
4.47 |
0.584 |
|
1.59 |
|
FCF, bln rub |
? |
|
-159.9 |
-2.92 |
-283.0 |
-208.4 |
-116.5 |
|
205.6 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
195.8 |
175.1 |
557.8 |
393.7 |
1 985 |
|
770.1 |
|
Cost of production, bln rub |
|
|
449.7 |
590.5 |
1 551 |
3 454 |
1 776 |
|
358.3 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
39.1 |
57.1 |
16.9 |
1.36 |
0.007 |
|
0.000 |
|
|
Assets, bln rub |
|
|
0.100 |
267.3 |
950.8 |
808.6 |
570.7 |
|
653.0 |
|
Net Assets, bln rub |
? |
|
-0.018 |
-568.4 |
539.3 |
347.7 |
286.4 |
|
342.2 |
|
Debt, bln rub |
|
|
57.9 |
0.806 |
27.8 |
5.86 |
4.66 |
|
3.67 |
|
Cash, bln rub |
|
|
67.6 |
151.1 |
791.2 |
555.3 |
242.7 |
|
333.1 |
|
Net debt, bln rub |
|
|
-9.68 |
-150.3 |
-763.4 |
-549.4 |
-238.0 |
|
-329.4 |
|
|
Ordinary share price, rub |
|
|
|
16.8 |
3.72 |
0.930 |
0.952 |
|
1.01 |
|
Number of ordinary shares, mln |
|
|
103.5 |
88.7 |
412.9 |
476.2 |
482.2 |
|
490.2 |
|
|
Market cap, bln rub |
|
|
0 |
1 487 |
1 536 |
443 |
459 |
|
495 |
|
EV, bln rub |
? |
|
-10 |
1 337 |
773 |
-107 |
221 |
|
166 |
|
Book value, bln rub |
|
|
-4 |
-573 |
535 |
328 |
283 |
|
342 |
|
|
EPS, rub |
? |
|
-3.89 |
-1.68 |
-1.46 |
-0.64 |
-0.44 |
|
-0.01 |
|
FCF/share, rub |
|
|
-1.54 |
-0.03 |
-0.69 |
-0.44 |
-0.24 |
|
0.42 |
|
BV/share, rub |
|
|
-0.04 |
-6.46 |
1.30 |
0.69 |
0.59 |
|
0.70 |
|
|
EBITDA margin, % |
? |
|
-39.5% |
-11.7% |
-38.7% |
-9.69% |
-10.4% |
|
-3.92% |
|
Net margin, % |
? |
|
-87.1% |
-22.1% |
-41.1% |
-8.78% |
-10.5% |
|
-0.26% |
|
FCF yield, % |
? |
|
|
-0.20% |
-18.4% |
-47.1% |
-25.4% |
|
41.5% |
|
ROE, % |
? |
|
2 284 641% |
26.2% |
-112.1% |
-87.8% |
-74.5% |
|
-1.02% |
|
ROA, % |
? |
|
-401 416% |
-55.6% |
-63.6% |
-37.8% |
-37.4% |
|
-0.54% |
|
|
P/E |
? |
|
0.00 |
-10.0 |
-2.54 |
-1.45 |
-2.15 |
|
-141.7 |
|
P/FCF |
|
|
0.00 |
-509.3 |
-5.43 |
-2.12 |
-3.94 |
|
2.41 |
|
P/S |
? |
|
0.00 |
2.21 |
1.04 |
0.13 |
0.23 |
|
0.36 |
|
P/BV |
? |
|
0.00 |
-2.60 |
2.87 |
1.35 |
1.62 |
|
1.45 |
|
EV/EBITDA |
? |
|
0.05 |
-17.0 |
-1.36 |
0.32 |
-1.05 |
|
-3.09 |
|
Debt/EBITDA |
|
|
0.05 |
1.91 |
1.34 |
1.63 |
1.13 |
|
6.14 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.00% |
0.10% |
0.05% |
0.13% |
0.03% |
|
0.12% |
|
| Clover Health Investments shareholders |
